DE69334129D1 - Modulierung der TNF-Rezeptoraktivität - Google Patents

Modulierung der TNF-Rezeptoraktivität

Info

Publication number
DE69334129D1
DE69334129D1 DE69334129T DE69334129T DE69334129D1 DE 69334129 D1 DE69334129 D1 DE 69334129D1 DE 69334129 T DE69334129 T DE 69334129T DE 69334129 T DE69334129 T DE 69334129T DE 69334129 D1 DE69334129 D1 DE 69334129D1
Authority
DE
Germany
Prior art keywords
tnf
modulation
receptor activity
tnf receptor
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69334129T
Other languages
English (en)
Other versions
DE69334129T2 (de
Inventor
David Wallach
Cord Brakebusch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of DE69334129D1 publication Critical patent/DE69334129D1/de
Publication of DE69334129T2 publication Critical patent/DE69334129T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69334129T 1992-05-03 1993-04-29 Modulierung der TNF-Rezeptoraktivität Expired - Lifetime DE69334129T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL101769A IL101769A (en) 1992-05-03 1992-05-03 Modulation of TNF receptor action
IL101769 1992-05-03

Publications (2)

Publication Number Publication Date
DE69334129D1 true DE69334129D1 (de) 2007-05-10
DE69334129T2 DE69334129T2 (de) 2007-12-13

Family

ID=11063598

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69334129T Expired - Lifetime DE69334129T2 (de) 1992-05-03 1993-04-29 Modulierung der TNF-Rezeptoraktivität

Country Status (8)

Country Link
US (4) US6395267B1 (de)
EP (2) EP0568925B1 (de)
JP (2) JP3712746B2 (de)
AT (1) ATE358178T1 (de)
DE (1) DE69334129T2 (de)
DK (1) DK0568925T3 (de)
ES (1) ES2281070T3 (de)
IL (1) IL101769A (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10399023I2 (de) 1989-09-12 2006-11-23 Ahp Mfg B V TFN-bindende Proteine
IL101769A (en) * 1992-05-03 2007-02-11 Yeda Res & Dev Modulation of TNF receptor action
US6100042A (en) 1993-03-31 2000-08-08 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US6864060B1 (en) 1993-03-31 2005-03-08 Cadus Technologies, Inc. Yeast cells expressing modified G proteins and methods of use therefor
US7235648B1 (en) 1993-03-31 2007-06-26 Cadus Technologies, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US20030054402A1 (en) 1993-03-31 2003-03-20 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
IL107268A0 (en) * 1993-10-12 1994-01-25 Yeda Res & Dev Molecules influencing the shedding of the tnf receptor, their preparation and their use
US5420109A (en) * 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
JPH09512704A (ja) * 1994-03-17 1997-12-22 ナシヨナル・ジユーイツシユ・センター・フオー・イミユノロジー・アンド・レスピラトリー・メデイシン シグナル変換経路を調節するための産物および方法
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
DE69634774T2 (de) * 1995-02-22 2006-02-02 Yeda Research And Development Co., Ltd. Modulatoren von regulationsproteinen
US6355780B1 (en) 1995-02-22 2002-03-12 Yeda Research And Development Co. Ltd. Antibodies to the death domain motifs of regulatory proteins
IL114461A0 (en) * 1995-07-05 1995-11-27 Yeda Res & Dev TNF modulation
US7416877B1 (en) * 1996-10-04 2008-08-26 Immunex Corporation Receptor that causes cell death and recombinant production thereof
NZ335864A (en) 1996-11-06 2001-09-28 Univ California Isolated tumor necrosis factor receptor releasing enzyme (TRRE), compositions comprising the enzyme and methods of the use in modulation of TNF levels
US6893838B1 (en) 1998-04-07 2005-05-17 Genetics Institute Llc DADD, death activator death domain protein
US6355473B1 (en) 1998-05-06 2002-03-12 Cadus Pharmaceutical Corp. Yeast cells having mutations in stp22 and uses therefor
US7081360B2 (en) 1998-07-28 2006-07-25 Cadus Technologies, Inc. Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties
US7273747B2 (en) 1998-08-27 2007-09-25 Cadus Technologies, Inc. Cell having amplified signal transduction pathway responses and uses therefor
US6251605B1 (en) 1998-10-27 2001-06-26 Cadus Pharmaceutical Corporation Yeast cells having mutations in Cav1 and uses therefor
AU2030000A (en) 1998-11-25 2000-06-13 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
IL178921A0 (en) * 1998-12-24 2007-03-08 Yeda Res & Dev Caspase-8 interacting proteins
US6504008B1 (en) 1999-02-01 2003-01-07 Cadus Technologies, Inc. Cell based signal generation
US6555325B1 (en) 1999-06-14 2003-04-29 Cadus Technologies, Inc. System for detection of a functional interaction between a compound and a cellular signal transduction component
US7223533B2 (en) 1999-09-10 2007-05-29 Cadus Technologies, Inc. Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways
US20080008713A1 (en) * 2002-06-28 2008-01-10 Domantis Limited Single domain antibodies against tnfr1 and methods of use therefor
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
US20060002935A1 (en) * 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
EP1460088A1 (de) 2003-03-21 2004-09-22 Biotest AG Humanisierter Antikörper gegen CD4 mit immunsuppressiven Merkmalen
EP1635765B1 (de) 2003-05-23 2013-07-17 Board Of Regents, The University Of Texas System Strukturbasiertes und kombinatorisch ausgewähltes oligonucleosid-phosphorothioat und phosphorodithioat aptamer targeting ap-1 transkriptionsfaktoren
KR20100135808A (ko) 2008-03-13 2010-12-27 바이오테스트 아게 질병 치료제
ES2569217T3 (es) 2008-03-13 2016-05-09 Biotest Ag Agente para tratar enfermedades
MX2010010028A (es) 2008-03-13 2011-08-17 Biotest Ag Agente para tratar enfermedad.
JP5746191B2 (ja) * 2009-10-19 2015-07-08 ハナル バイオファーマ カンパニーリミテッドＨａｎＡｌｌ Ｂｉｏｐｈａｒｍａ Ｃｏ．， Ｌｔｄ． 修飾されたヒト腫瘍壊死因子受容体−１ポリペプチドまたはその断片及びその製造方法
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease
EP2657252B1 (de) * 2010-12-23 2017-03-08 HanAll Biopharma Co., Ltd. Modifiziertes menschliches tumornekrose-faktor-rezeptor-1-polypeptid oder fragment davon sowie herstellungsverfahren dafür
DE102013223589B4 (de) 2013-11-19 2016-11-17 Hydrogenious Technologies Gmbh Anlage und Verfahren zum Speichern von Energie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94039A (en) * 1989-08-06 2006-09-05 Yeda Res & Dev Antibodies to tbp - 1 and their use
US5811261A (en) * 1988-09-12 1998-09-22 Yeda Research And Development Co. Ltd. Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
ES2238070T3 (es) * 1989-04-21 2005-08-16 Amgen Inc. Receptor del tnf, proteina ligante del tnf y adn codante para estos.
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DE4006269A1 (de) * 1990-02-28 1991-08-29 Max Planck Gesellschaft Antikoerper gegen den tumor-nekrosefaktor-rezeptor
IL101769A (en) * 1992-05-03 2007-02-11 Yeda Res & Dev Modulation of TNF receptor action

Also Published As

Publication number Publication date
DE69334129T2 (de) 2007-12-13
US7056505B2 (en) 2006-06-06
ATE358178T1 (de) 2007-04-15
US20020142357A1 (en) 2002-10-03
IL101769A0 (en) 1992-12-30
JP3712746B2 (ja) 2005-11-02
DK0568925T3 (da) 2007-05-29
US7728111B2 (en) 2010-06-01
EP1512697A1 (de) 2005-03-09
US20090088558A1 (en) 2009-04-02
ES2281070T3 (es) 2007-09-16
US6395267B1 (en) 2002-05-28
IL101769A (en) 2007-02-11
JP3683263B2 (ja) 2005-08-17
JPH06233684A (ja) 1994-08-23
EP0568925B1 (de) 2007-03-28
JP2004340975A (ja) 2004-12-02
US7429379B2 (en) 2008-09-30
EP0568925A2 (de) 1993-11-10
EP0568925A3 (de) 1995-03-15
US20060210560A1 (en) 2006-09-21

Similar Documents

Publication Publication Date Title
ATE358178T1 (de) Modulierung der tnf-rezeptoraktivität
DE69431805T2 (de) Struktur höherer ordnung und bindung von peptidnukleinsäuren
DE69333027D1 (de) Fusionsprotein , das zwei rezeptoren des tumornekrose-faktors enthält
DK0964874T3 (da) CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf
DK0759067T3 (da) Transformerende vækstfaktor alfa-H1
AU6803790A (en) Expression of the recombinant tumor necrosis factor binding protein 1 (TBP-1)
NO963818L (no) Forhöyet utskillelse av polypeptider
EA200000311A1 (ru) Новый белок иммунной системы - кау
FI960786A0 (fi) Komponentteja ja katalyytteja olefiinien polymerisoimiseksi
FI862756A (fi) Fibroektiner.
EA200000449A1 (ru) Модифицированные витамины к-зависимые полипептиды
GR3036782T3 (en) Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.
BG109537A (en) FUNCTION MODULATORS OF RECEPTORS OF TNF / NGF RECIPE FAMILY AND OTHER PROTEINS
DE68916740D1 (de) Verbessertes Methatese-Katalysator-System zur Polimerisation von Dicyclopentadien.
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
EP1568708A3 (de) Verfahren und medizinische Verwendungen von Nukleinsäuren die für einen TRAF-Inhibitor kodieren
ES8706827A1 (es) Procedimiento para preparar polipeptidos.
DE68923636D1 (de) Halbleiter-Treiber zur Erzeugung von Schalt- und Offset-Signalen.
DE68918759T2 (de) Schalter mit einem "NCAP" Flüssigkristall.
AU7117687A (en) Combination therapy using interleukin-2 and tumor necrosis factor
DK0606869T3 (da) Promotorsekvens for p55-receptoren for tumornekrosefaktor
DE68922523T2 (de) Reaktionsprodukt von Beta-Diketo-Verbindung mit Polymer und Verwendung davon.
DE68908004D1 (de) Verwendung von karbon-materialien.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition